Colleen M Cunningham
Colleen M Cunningham
Assistant Professor of Strategy & Entrepreneurship, London Business School
Verified email at london.edu
TitleCited byYear
The cost of drug development: a systematic review
S Morgan, P Grootendorst, J Lexchin, C Cunningham, D Greyson
Health policy 100 (1), 4-17, 2011
3932011
Patterns in the use of benzodiazepines in British Columbia: examining the impact of increasing research and guideline cautions against long-term use
CM Cunningham, GE Hanley, S Morgan
Health policy 97 (2-3), 122-129, 2010
832010
Killer acquisitions
C Cunningham, F Ederer, S Ma
552018
Population aging and the determinants of healthcare expenditures: the case of hospital, medical and pharmaceutical care in British Columbia, 1996 to 2006
S Morgan, C Cunningham
Healthcare Policy 7 (1), 68-79, 2011
322011
Information behaviour of Canadian pharmaceutical policy makers
DL Greyson, C Cunningham, S Morgan
Health Information & Libraries Journal 29 (1), 16-27, 2012
312012
Ethnic differences in the use of prescription drugs: a cross-sectional analysis of linked survey and administrative data
S Morgan, G Hanley, C Cunningham, H Quan
Open Medicine 5 (2), e87, 2011
232011
The British Columbia Rx Atlas
S Morgan, C Cunningham, G Hanley, D Mooney
University of British Columbia. Centre for Health Services and Policy Research, 2009
232009
Racial and ethnic disparities in the use of antipsychotic medication: a systematic review and meta-analysis
JH Puyat, JR Daw, CM Cunningham, MR Law, ST Wong, DL Greyson, ...
Social psychiatry and psychiatric epidemiology 48 (12), 1861-1872, 2013
182013
Individual and contextual determinants of regional variation in prescription drug use: an analysis of administrative data from British Columbia
SG Morgan, CM Cunningham, GE Hanley
PLoS One 5 (12), 2010
172010
The effect of evidence-based drug coverage policies on pharmaceutical R&D: A case study from British Columbia
S Morgan, C Cunningham
Healthcare Policy 3 (3), e128, 2008
142008
Drug development: innovation or imitation deficit?
SG Morgan, CM Cunningham, MR Law
Bmj 345, e5880, 2012
102012
Ethnic disparities in antipsychotic drug use in British Columbia: a cross-sectional retrospective study
JH Puyat, GE Hanley, CM Cunningham, MR Law, ST Wong, ...
Psychiatric Services, 2011
102011
Income inequities in end-of-life health care spending in British Columbia, Canada: A cross-sectional analysis, 2004-2006
CM Cunningham, GE Hanley, SG Morgan
International journal for equity in health 10 (1), 12, 2011
92011
The limits of relational governance: Sales force strategies in the US medical device industry
AK Chatterji, CM Cunningham, JE Joseph
Strategic Management Journal, 2018
32018
When does novelty pay?
CM Cunningham
Academy of Management Proceedings 2017 (1), 16957, 2017
32017
Listening for prescriptions: a national consultation on pharmaceutical policy issues
S Morgan, CM Cunningham
Healthcare Policy 6 (2), 48, 2010
32010
Inventive Capabilities in the Division of Innovative Labor
A Arora, WM Cohen, CM Cunningham
National Bureau of Economic Research Working Paper Series, 2018
22018
Experimenting strategically: inter-firm relationships and “in the field” innovation
A Kapacinskaite, C Cunningham
Academy of Management Proceedings 2019 (1), 17571, 2019
2019
Paper to be presented at DRUID19 Copenhagen Business School, Copenhagen, Denmark June 19-21, 2019
A Kapacinskaite, C Cunningham
2019
The Management, Organization, and Geography of Novel Innovation
CM Cunningham
Duke University, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–20